KOPS - The Institutional Repository of the University of Konstanz

Bioinformatics analysis of the serine and glycine pathway in cancer cells

Bioinformatics analysis of the serine and glycine pathway in cancer cells

Cite This

Files in this item

Checksum: MD5:7c96b3e03e2878630ef7bd4cae4a06ae

ANTONOV, Alexey, Massimiliano AGOSTINI, Maria MORELLO, Marilena MINIERI, Gerry MELINO, Ivano AMELIO, 2014. Bioinformatics analysis of the serine and glycine pathway in cancer cells. In: Oncotarget. Impact Journals LLC. 5(22), pp. 11004-11013. eISSN 1949-2553. Available under: doi: 10.18632/oncotarget.2668

@article{Antonov2014Bioin-57082, title={Bioinformatics analysis of the serine and glycine pathway in cancer cells}, year={2014}, doi={10.18632/oncotarget.2668}, number={22}, volume={5}, journal={Oncotarget}, pages={11004--11013}, author={Antonov, Alexey and Agostini, Massimiliano and Morello, Maria and Minieri, Marilena and Melino, Gerry and Amelio, Ivano} }

<rdf:RDF xmlns:dcterms="http://purl.org/dc/terms/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bibo="http://purl.org/ontology/bibo/" xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:void="http://rdfs.org/ns/void#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > <rdf:Description rdf:about="https://kops.uni-konstanz.de/rdf/resource/123456789/57082"> <dcterms:issued>2014</dcterms:issued> <dc:contributor>Morello, Maria</dc:contributor> <dc:creator>Amelio, Ivano</dc:creator> <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/rdf/resource/123456789/28"/> <bibo:uri rdf:resource="https://kops.uni-konstanz.de/handle/123456789/57082"/> <dc:contributor>Antonov, Alexey</dc:contributor> <dc:contributor>Melino, Gerry</dc:contributor> <dcterms:rights rdf:resource="https://rightsstatements.org/page/InC/1.0/"/> <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/rdf/resource/123456789/28"/> <dc:creator>Antonov, Alexey</dc:creator> <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2022-03-30T09:16:03Z</dc:date> <foaf:homepage rdf:resource="http://localhost:8080/jspui"/> <dc:contributor>Minieri, Marilena</dc:contributor> <dcterms:title>Bioinformatics analysis of the serine and glycine pathway in cancer cells</dcterms:title> <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2022-03-30T09:16:03Z</dcterms:available> <dc:creator>Agostini, Massimiliano</dc:creator> <dc:contributor>Agostini, Massimiliano</dc:contributor> <dc:language>eng</dc:language> <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/> <dcterms:hasPart rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/57082/1/Antonov_2-g3tii6mnt93c3.pdf"/> <dcterms:abstract xml:lang="eng">Serine and glycine are amino acids that provide the essential precursors for the synthesis of proteins, nucleic acids and lipids. Employing 3 subsequent enzymes, phosphoglycerate dehydrogenase (PHGDH), phosphoserine phosphatase (PSPH), phosphoserine aminotransferase 1 (PSAT1), 3-phosphoglycerate from glycolysis can be converted in serine, which in turn can by converted in glycine by serine methyl transferase (SHMT). Besides proving precursors for macromolecules, serine/glycine biosynthesis is also required for the maintenance of cellular redox state. Therefore, this metabolic pathway has a pivotal role in proliferating cells, including cancer cells. In the last few years an emerging literature provides genetic and functional evidences that hyperactivation of serine/glycine biosynthetic pathway drives tumorigenesis. Here, we extend these observations performing a bioinformatics analysis using public cancer datasets. Our analysis highlighted the relevance of PHGDH and SHMT2 expression as prognostic factor for breast cancer, revealing a substantial ability of these enzymes to predict patient survival outcome. However analyzing patient datasets of lung cancer our analysis reveled that some other enzymes of the pathways, rather than PHGDH, might be associated to prognosis. Although these observations require further investigations they might suggest a selective requirement of some enzymes in specific cancer types, recommending more cautions in the development of novel translational opportunities and biomarker identification of human cancers.</dcterms:abstract> <dc:creator>Morello, Maria</dc:creator> <dc:contributor>Amelio, Ivano</dc:contributor> <dc:creator>Melino, Gerry</dc:creator> <dc:creator>Minieri, Marilena</dc:creator> <dc:rights>terms-of-use</dc:rights> <dspace:hasBitstream rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/57082/1/Antonov_2-g3tii6mnt93c3.pdf"/> </rdf:Description> </rdf:RDF>

Downloads since Mar 30, 2022 (Information about access statistics)

Antonov_2-g3tii6mnt93c3.pdf 14

This item appears in the following Collection(s)

Search KOPS


Browse

My Account